Seres Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.

About MCRB

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. 

CEO
Thomas J. DesRosier
CEOThomas J. DesRosier
Employees
103
Employees103
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
103
Employees103

MCRB Key Statistics

Market cap
130.44M
Market cap130.44M
Price-Earnings ratio
-1.83
Price-Earnings ratio-1.83
Dividend yield
—
Dividend yield—
Average volume
122.55K
Average volume122.55K
High today
$15.23
High today$15.23
Low today
$14.36
Low today$14.36
Open price
$14.82
Open price$14.82
Volume
29.31K
Volume29.31K
52 Week high
$26.40
52 Week high$26.40
52 Week low
$6.53
52 Week low$6.53

MCRB News

Seeking Alpha 6d
Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

Earnings Call Insights Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks Aug. 06, 2025 9:48 PM ET Ser...

Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

People also own

Based on the portfolios of people who own MCRB. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Plug Power
Tilray Brands
Workhorse
SNDL
Lucid Group
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.